Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
BY WEIGHT
10
# OF OVERLAPPING HOLDINGS
MEDX
28
HOLDINGS
36%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.4% | 18.6% | 16.4% |
 |
NOVARTIS AG-ADR | 7.3% | 7.6% | 7.3% |
|
JOHNSON & JOHNSON | 4.8% | 10.1% | 4.8% |
|
ABBVIE INC | 8.8% | 4.4% | 4.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% | 4.4% | 4.4% |
MEDX Overweight Relative to PPH
|
AMGEN INC | 5.9% |
|
ALNYLAM PHARMACEUTICALS INC | 5.9% |
|
ABBVIE INC | 4.4% |
 |
ALKERMES PLC | 4.2% |
|
CRISPR THERAPEUTICS AG | 3.2% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
|
BIOGEN IDEC INC | 2.5% |
|
REGENERON PHARMACEUTICALS | 2.4% |
|
ASTRAZENECA PLC-SPONS ADR | 1.1% |
|
BEAM THERAPEUTICS, INC. | 1.0% |
MEDX Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -7.5% |
|
JOHNSON & JOHNSON | -5.2% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.5% |
|
ZOETIS INC | -4.4% |
|
CENCORA INC | -3.9% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |
|
MERCK & CO. INC. | -2.5% |
|
ELI LILLY & CO | -2.1% |
 |
TEVA PHARMACEUTICAL-SP ADR | -1.6% |